TNF alpha antibody and other cytokine antibodies: detection, capture or blocking

Choosing for the job

1. Decide detection, capture or neutralisation first. A detection antibody binds on a blot or a section. A capture antibody works as half of a matched pair in an immunoassay. A neutralising antibody blocks a function and must show a dose response in a cell assay. These are three products and a datasheet that lists all three needs evidence for all three.
2. Establish which form the antibody sees. Several of these cytokines are made as a precursor and cleaved to a mature form, and some circulate bound to soluble receptors. An antibody against the precursor region reports something different from one against the mature protein, and this explains a great deal of disagreement between published measurements.
3. Use matched pairs for immunoassay, from one supplier. Capture and detection antibodies must bind different epitopes without blocking each other. Assembling a pair from two independently chosen antibodies is a development project; buying a validated pair is a purchase.
4. Specify carrier-free and low endotoxin for cell work. Anything added to living cells needs a stated endotoxin limit, no azide and no bovine carrier protein. Endotoxin in a cytokine experiment is a particularly bad contaminant, because it induces the very cytokines you are measuring.
5. Check species reactivity was tested, not predicted. Cytokines are less conserved than their names suggest, and cross-reactivity predicted from sequence often fails in practice. For a model organism, ask for data in that species and for neutralisation specifically, where potency differs even when binding does not.

CXCL9 antibody and CXCL10 antibody: cross-reactivity in a chemokine family

CXCL9 and CXCL10 are induced by the same signal, share a receptor and are frequently measured together, which makes cross-reactivity between reagents an active concern rather than a theoretical one. Ask for cross-reactivity data against the closest family members.

Where both are measured, a multiplex panel validated as a set is safer than two independently chosen assays, because the supplier has had to demonstrate the pair does not interfere.

Pre-analytical handling moves the number

Several of these cytokines are released from leucocytes and platelets during clotting, so serum and plasma values differ substantially for the same donor. Fix the tube type, the time to centrifugation and the storage, and apply them to every sample.

Record the handling with the result. Most disagreements between published cytokine values come down to pre-analytical protocol rather than to the assay.

Reading a blocking experiment

Run a full dose response with an isotype control at the same concentrations, and include a positive control that blocks by another mechanism where one exists. A single concentration showing a difference is not a demonstration of neutralisation.

Check the antibody is not simply toxic at the concentration used. A viability readout alongside the functional one separates blocking from killing, and it costs one extra plate.

Membrane forms, shedding and what a stain means

Several chemokines and ligands exist both as a membrane-anchored protein and as a soluble form released by proteolysis, and the biology frequently depends on which is present. A tissue stain showing signal at the cell surface and an assay reporting a soluble concentration are measuring different halves of one system.

Ask whether the epitope survives shedding before choosing the reagent. An antibody raised against the region removed by cleavage detects only the uncleaved form, which is either exactly what you want or exactly what invalidates the experiment, and the product page rarely says which.

Latency: measuring a factor that circulates inactive, with a TGF-beta 1 antibody

Where a factor circulates in a latent complex, an assay reports either the active fraction or the total after an activation step, and the two numbers are far apart. Which one you are reporting has to be stated, because a treatment that changes activation will otherwise read as a change in amount.

Keep the activation step identical across conditions and across time points. The most common irreproducible result in this part of the catalogue is a comparison between samples activated slightly differently, and it is invisible unless the protocol records it.

A granzyme B antibody as a readout of cell state

An antibody against a cytotoxic effector protein is generally being used to say that a cell is armed rather than that it has killed anything. Intracellular staining reports content, which rises with activation and falls after release, so the same measurement can mean opposite things at different times.

Pair it with a functional readout wherever the claim is activity, and state the time point in the methods. This is the commonest over-interpretation in the category and it is a design problem rather than a reagent one.

Common questions

Is a tnf alpha antibody the same as a tnf-alpha antibody?

The hyphen is a naming convention rather than a difference, and suppliers use both. What differs between products is the clone, the epitope and whether the reagent was validated for detection, capture or neutralisation.

How do I know an antibody neutralises?

A cell-based functional assay with a dose response and a stated half-maximal inhibitory concentration in a named system. Binding data, however strong, is not evidence of blocking and the two are frequently shown together.

Why do two IL-1b antibody assays disagree about a cytokine concentration?

Different antibody pairs see different forms, including precursor, mature and receptor-bound cytokine, and standards are calibrated differently. Values from two kits are generally not interchangeable.

What grade do I need to add antibody to cells?

Carrier-free, azide-free, sterile filtered and with a stated endotoxin limit. Endotoxin is the contaminant that matters most here because it stimulates cytokine production directly.

Why do two IL-6 antibody immunoassays report different concentrations?

Usually because they are calibrated against different recombinant standards, and often because they detect different forms of the protein. Compare assays only when the standard and the forms detected are both stated.

Browse by service class

• Compare Gene synthesis on advertised prices